Action of anticholinergic drugs on striatal dopamine.
D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology; D001921:Brain / Q000648:ultrastructure; D002395:Catecholamines / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013329:Structure-Activity Relationship; D013574:Synaptosomes / Q000378:metabolism
D000662:Amphetamines; D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D002395:Catecholamines; D010276:Parasympatholytics; D004298:Dopamine